Sigyn Therapeutics Announces Virtual Presentation Today at the LD Micro Invitational Conference
SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announced that its Chairman and CEO, Jim Joyce will give a virtual presentation today at the LD Micro Invitational Conference.
- SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announced that its Chairman and CEO, Jim Joyce will give a virtual presentation today at the LD Micro Invitational Conference.
- A live audio webcast and archive of the event presentation will be available using the webcast link above.
- Sigyn Therapy incorporates a cocktail of adsorbent components to optimize therapeutic target elimination without the risk of blood cell interactions.
- This press release contains forward-looking statements of Sigyn Therapeutics, Inc. (Sigyn) that involve substantial risks and uncertainties.